Stathmin guides personalized therapy in oral squamous cell carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stathmin guides personalized therapy in oral squamous cell carcinoma
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-01-29
DOI
10.1111/cas.14323
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions
- (2018) R I Haddad et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting the PI3K pathway in cancer: are we making headway?
- (2018) Filip Janku et al. Nature Reviews Clinical Oncology
- An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis
- (2018) Changlei Zhao et al. MEDICAL SCIENCE MONITOR
- Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE)
- (2017) Sibylle Loibl et al. EUROPEAN JOURNAL OF CANCER
- Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma
- (2017) Hai-long Ma et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Denis Soulières et al. LANCET ONCOLOGY
- Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy
- (2017) Zili Wang et al. Oncology Letters
- Deconvolution of Buparlisib’s mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic intervention
- (2017) Thomas Bohnacker et al. Nature Communications
- A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2− advanced breast cancer (BELLE-4)
- (2016) M. Martín et al. ANNALS OF ONCOLOGY
- Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years’ discoveries and developments
- (2016) Rong Biaoxue et al. Journal of Translational Medicine
- High expression of stathmin 1 is a strong prognostic marker in oral squamous cell carcinoma patients treated by docetaxel-containing regimens
- (2015) Koji Harada et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions
- (2015) Steven B. Chinn et al. JOURNAL OF CLINICAL ONCOLOGY
- Op18/Stathmin Is Involved in the Resistance of Taxol Among Different Epithelial Carcinoma Cell Lines
- (2014) Xuechi Lin et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer
- (2014) Wei Nie et al. LABORATORY INVESTIGATION
- Unbiased Proteomic and Transcript Analyses Reveal that Stathmin-1 Silencing Inhibits Colorectal Cancer Metastasis and Sensitizes to 5-Fluorouracil Treatment
- (2014) W. Wu et al. MOLECULAR CANCER RESEARCH
- Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling
- (2014) Simon Schimmack et al. TUMOR BIOLOGY
- High Phospho-Stathmin(Serine38) Expression Identifies Aggressive Endometrial Cancer and Suggests an Association with PI3K Inhibition
- (2013) E. Wik et al. CLINICAL CANCER RESEARCH
- Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer
- (2012) Maria T. Baquero et al. CANCER
- Randomized Phase III Trial of Induction Chemotherapy With Docetaxel, Cisplatin, and Fluorouracil Followed by Surgery Versus Up-Front Surgery in Locally Advanced Resectable Oral Squamous Cell Carcinoma
- (2012) Lai-ping Zhong et al. JOURNAL OF CLINICAL ONCOLOGY
- The multiple roles of Bub1 in chromosome segregation during mitosis and meiosis
- (2011) Francesco Marchetti et al. CELL CYCLE
- Lifestyle impacts on the aging-associated expression of biomarkers of DNA damage and telomere dysfunction in human blood
- (2010) Zhangfa Song et al. AGING CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now